Inspire(US:INSP) Prnewswire·2025-11-26 21:25Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding the launch and performance of its Inspire V Device, which has reportedly underperformed in the market [1][3][4]. Company Overview - Inspire Medical Systems, Inc. is a medical technology company that develops and manufactures an implantable device for treating obstructive sleep apnea, known as the Inspire V Device [1][3]. Allegations and Issues - The lawsuit claims that the company misrepresented the potential of the Inspire V Device, which was marketed as groundbreaking but faced poor demand and significant inventory issues among providers [3][4]. - Key failures cited include inadequate training for treatment centers, lack of essential IT systems, and unpreparedness for insurance claims processing, which were critical for a successful product launch [4]. Financial Impact - On August 4, 2025, the company announced a significant reduction in its 2025 earnings guidance by over 80%, dropping from a range of $2.20 to $2.30 per share to just $0.40 to $0.50 per share [5]. - Following this announcement, the stock price plummeted by $42.04 per share, a decline of more than 32%, resulting in a loss of $1.2 billion in market capitalization in a single day [5]. - From a high of $216.71 per share on September 23, 2024, the stock has decreased by nearly 60%, erasing billions from the company's market capitalization [5].